News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Noninvasive, personalized neuromodulation promising for obsessive-compulsive behavior
By Marilynn Larkin NEW YORK (Reuters Health) - Alternating current targeted to the orbitofrontal cortex and personalized to the brain's reward center improved obsessive compulsive behaviors for three
EU kicks off debate on vaccine travel certificates
By Philip Blenkinsop BRUSSELS (Reuters) - European Union countries kicked off a debate on Monday on whether people who have received a COVID-19 vaccine should have greater freedom to travel in the
More patients use crowdsourced fundraising campaigns to cover healthcare costs
By Carolyn Crist NEW YORK (Reuters Health) - U.S. patients are using online fundraising platforms to raise money for their healthcare costs, particularly for cancer and injuries -- and unemployment
Primary care providers account for small proportion of low-value care
By Lisa Rapaport (Reuters Health) - Primary care providers account for very little of the low-value services received by Medicare beneficiaries, a new U.S. study suggests. Researchers examined data
Skin damage from UV light seen in sun-shielded skin
By Marilynn Larkin NEW YORK (Reuters Health) - UV light-related skin damage is common even in skin cells typically shielded from the sun, regardless of a person's age, whereas endogenous DNA skin
Calcium chloride during CABG curbs subsequent atrial fibrillation
By David Douglas NEW YORK (Reuters Health) - Injecting calcium chloride (CaCl2) into the major atrial ganglionated plexi (GP) during isolated coronary-artery bypass grafting (CABG) appears to prompt a
Facing high drug costs, some U.S. cancer survivors buy prescriptions abroad
By Carolyn Crist NEW YORK (Reuters Health) - U.S. cancer survivors who face difficulties in finding a doctor and affording their medications are more likely to purchase their prescriptions outside of
REFILE-Time to broaden warning on fluoroquinolones to all adults?
(Adds slug, with no changes to text.) By Reuters Staff NEW YORK (Reuters Health) - A new study confirms and strengthens the association between fluoroquinolone antibiotics and increased risk of aortic
Time to broaden warning on fluoroquinolones to all adults?
By Reuters Staff NEW YORK (Reuters Health) - A new study confirms and strengthens the association between fluoroquinolone antibiotics and increased risk of aortic aneurysm, prompting calls to broaden
Barrett's esophagus common in women with scleroderma
By Reuters Staff NEW YORK (Reuters Health) - Barrett's esophagus (BE) is common in women with systemic sclerosis or scleroderma (SSc) and is often accompanied by dysplasia, according to the largest
Virtual post-discharge follow-up visits work for low-risk surgeries
By Megan Brooks NEW YORK (Reuters Health) - Virtual follow-up visits work well for patients who have had minimally invasive appendectomy or cholecystectomy, new research indicates. "Post-discharge
US and China clash at WHO over scientific mission in Wuhan
By Reuters Staff GENEVA (Reuters) - The United States called on China on Monday to allow an expert team from the World Health Organization (WHO) to interview "care givers, former patients and lab
Multivalent nanobodies block coronavirus, even when it mutates
By Reuters Staff (Reuters) - Combining small antibodies called nanobodies into single molecules to block the novel coronavirus may be more effective than targeting it with conventional antibodies or
SARS-CoV-2 targets mitochondria
By Reuters Staff (Reuters) - Researchers have discovered an important line of attack used by the novel coronavirus: it targets the mitochondria, which not only generate the energy that powers a cell's
New olfactory dysfunction test may help diagnose mild COVID-19
By Marilynn Larkin NEW YORK (Reuters Health) - A new rapid test, the Clinical Olfactory Dysfunction Assessment (CODA), uses paper strips and essential oils to help in the diagnosis of COVID-19,
Ultra-early tranexamic acid of no benefit for subarachnoid hemorrhage
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with subarachnoid hemorrhage due to a ruptured aneurysm, ultra-early, short-term tranexamic acid (TXA) did not improve clinical outcomes in a
Assistive technology aids language learning in hearing-impaired children
By Lisa Rapaport (Reuters Health) – Children who are deaf or hard of hearing can learn to express themselves with longer phrases, take more turns in conversations, and develop more words in their
UPDATE 1-Biden names geneticist Lander for new Cabinet-level post, elevating role of science
(Adds comments by Lander, details on position) By Joey Roulette (Reuters) - U.S. President-elect Joe Biden named pioneering geneticist Eric Lander as the director of the Office of Science and
REFILE-Biden will keep Dr. Francis Collins as National Institutes of Health director - statement
(Corrects to "Institutes" in headline and first paragraph) By Reuters Staff WASHINGTON (Reuters) - U.S. President-elect Joe Biden will keep Dr. Francis Collins as head of the National Institutes of
Biden names geneticist Lander for new Cabinet-level post, elevating role of science
By Reuters Staff (Reuters) - U.S. President-elect Joe Biden will name pioneering geneticist Eric Lander as the director of the Office of Science and Technology Policy, his transition team said on
Biden will keep Dr. Francis Collins as National Institute of Health director - statement
By Reuters Staff WASHINGTON (Reuters) - U.S. President-elect Joe Biden will keep Dr. Francis Collins as head of the National Institute of Health, his transition team said in a press release Friday.
Men more likely to be infected with SARS-CoV-2, have worse outcomes
By Linda Carroll (Reuters Health) - Men appear to be more susceptible to SARS-CoV-2 infection, and to have worse outcomes across all adult age groups, a new study finds. An analysis of data from
Proposed revisions to lung-cancer-screening eligibility criteria may not go far enough
By Megan Brooks NEW YORK (Reuters Health) - Revised draft guidelines on lung-cancer screening from the U.S. Preventive Services Task Force (USPSTF) may increase rates of lung-cancer screening for
Brazil airlifts emergency oxygen in, sick babies out of pandemic-battered Manaus
By Bruno Kelly MANAUS, Brazil (Reuters) - Brazil's Air Force delivered emergency supplies of oxygen on Friday to the jungle state of Amazonas, and premature babies were to be airlifted to other states
UPDATE 1-Fast-spreading UK coronavirus variant could be dominant in U.S. by March, CDC says
(Recasts, adds details from report throughout, adds link to report) By Julie Steenhuysen CHICAGO (Reuters) - A new, highly transmissible variant of the coronavirus first discovered in Britain could
UPDATE 1-COVID-19 infection gives some immunity, but virus can still be spread, study finds
(Updates story originally published January 14 with link to study preprint) By Kate Kelland LONDON (Reuters) - People who have had COVID-19 are highly likely to have immunity to it for at least five
UPDATE 1-Biden chooses former FDA chief Kessler to help lead U.S. vaccine drive
(Recasts, adds 500,000 death prediction, details, quotes) By Trevor Hunnicutt (Reuters) - U.S. President-elect Joe Biden has chosen David Kessler, the ex-head of the Food and Drug Administration (FDA)
More transmissible UK coronavirus variant found in 10 U.S. states, CDC says
By Julie Steenhuysen CHICAGO (Reuters) - A new, more transmissible variant of the coronavirus first discovered in Britain has been detected in 10 U.S. states, the U.S. Centers for Disease Control and
EU eyes 'Vaxproof' document to revive travel, but concerns over vaccine hesitancy
By Francesco Guarascio BRUSSELS (Reuters) - The European Commission is working on a vaccine certificate, dubbed "Vaxproof", that could help restore cross-border travel, EU officials said, but the plan
EU states warn of risks to vaccination credibility as Pfizer slows supplies
By Francesco Guarascio and Andrius Sytas BRUSSELS/VILNUS (Reuters) - European governments said the credibility of their vaccination programmes was at risk on Friday after U.S. pharmaceutical firm
ANALYSIS-Biden's federal boost to vaccine rollout is critical to speeding inoculations
By Carl O'Donnell and Rebecca Spalding (Reuters) - President-elect Joe Biden's plan to boost the COVID-19 vaccine rollout, including by spending $20 billion to create mass vaccination centers, should
Dutch government quits over 'colossal stain' of tax subsidy scandal
By Stephanie van den Berg THE HAGUE (Reuters) - Prime Minister Mark Rutte's government resigned on Friday, accepting responsibility for wrongful accusations of fraud by the tax authorities that drove
South African scientists discover new chemicals that kill malaria parasite
JOHANNESBURG, Jan 15 (Reuters) - South African scientists have discovered chemical compounds that could potentially be used for a new line of drugs to treat malaria and even kill the parasite in its
EXCLUSIVE-International COVID-19 vaccine poll shows higher mistrust of Russia, China shots
By Kate Kelland LONDON (Reuters) - People across the world are generally likely to say yes to getting a COVID-19 vaccine, but would be more distrustful of shots made in China or Russia than those
Instagram influencers are a vaccine priority in wary Indonesia
By Stanley Widianto and Kate Lamb JAKARTA (Reuters) - Among the first in the queue for coronavirus vaccines in Indonesia has been one conspicuous group - social media influencers. Alongside President
Guatemalan families mourn death of children as hunger spreads
By Sofia Menchu LA PALMILLA, Guatemala (Reuters) - Two-year-old Yesmin Anayeli Perez died this week of illnesses linked to malnutrition, the third small child to die from similar causes in an
Group-based parenting programs help early childhood development in Kenya
By Carolyn Crist NEW YORK (Reuters Health) - Parenting programs in Kenya with peer groups of mothers and children improved cognitive, language and socioemotional development among young children,
Basophil activation test can limit need for oral food challenges in nut, seed allergies
By Scott Baltic NEW YORK (Reuters Health) - In children with one or more nut allergies who have undergone skin prick and specific IgE testing, the basophil activation test (BAT) can reduce the number
Benralizumab improves health-related quality of life in severe eosinophilic asthma
By Reuters Staff NEW YORK (Reuters Health) - Results of a phase-3b trial confirm and extend the efficacy of benralizumab for patients with severe eosinophilic asthma, showing early and sustained
Model to predict bleeding, thrombotic risks may help tailor PCI management
By David Douglas NEW YORK (Reuters Health) - Clinical decision-making at the time of percutaneous coronary intervention (PCI) in certain patients can be aided by a model which takes into account both
Racial disparities in common surgeries persist in the United States
By Megan Brooks NEW YORK (Reuters Health) - Despite national initiatives aimed at reducing racial disparities in healthcare, these disparities persist in patients undergoing major surgical procedures
WHO-led team in China will start meetings online from quarantine
By Thomas Peter and John Geddie WUHAN, China/SINGAPORE (Reuters) - A World Health Organization-led team investigating the origins of COVID-19 are to begin virtual meetings with their Chinese hosts
French mortality rate rose 9% in 2020 due to COVID-19
By Reuters Staff PARIS (Reuters) - France's overall mortality rate in 2020, inflated by the COVID-19 pandemic, was nine percent higher than in the previous two years, provisional data released by
Biden chooses ex FDA chief Kessler to help lead U.S. vaccine drive - NYT
By Reuters Staff (Reuters) - U.S. President-elect Joe Biden has chosen David Kessler, the ex-head of the Food and Drug Administration (FDA), to help lead the COVID-19 vaccine push Operation Warp Speed
FOCUS-Some U.S. nursing home residents face delays for COVID-19 vaccines despite extreme risk
By Lisa Baertlein and Deena Beasley LOS ANGELES (Reuters) - A former Arkansas health official is sounding alarms about the pace of coronavirus vaccines being administered to residents of long-term
More adults aged 40-59 have polyps greater than 9mm on colonoscopy
By Lisa and Rapaport (Reuters Health) - The proportion of adults 40 to 59 years old who have polyps larger than 9mm on colonoscopy has increased in recent years, a U.S. study suggests. Researchers
High-titer convalescent plasma lowers COVID-19 death rate but not in ventilator cases
By Reuters Staff (Reuters Health) - An analysis of 3,082 cases where COVID-19 patients received convalescent plasma has concluded that the treatment produces a significant chance of preventing death
European countries that implemented strict COVID-19 mitigation policies saw fewer deaths
By Linda Carroll (Reuters Health) - In Europe, countries that implemented strict COVID-19 mitigation policies early in the pandemic, including cancellation of public events, gathering restrictions,
New tool helps predict chemotherapy toxicity in older women with early breast cancer
By Megan Brooks NEW YORK (Reuters Health) - Researchers have developed and validated a simple risk-assessment tool that combines eight clinical and geriatric factors to gauge the likelihood of severe
Nanoparticle platform delivers drugs across blood-brain-barrier in mice
By Marilynn Larkin NEW YORK (Reuters Health) - A novel nanoparticle drug delivery system had a therapeutic effect in a mouse model of traumatic brain injury (TBI), regardless of whether the
Quebec to give COVID-19 vaccine doses as many as 90 days apart
By Reuters Staff TORONTO (Reuters) - Quebec may space out doses of COVID-19 vaccines by as long as 90 days, the province said on Thursday, beyond the 42-day interval recommended by a national advisory
Chile keeps faith in Sinovac COVID-19 vaccine as Brazil data generates jitters elsewhere
By Aislinn Laing SANTIAGO (Reuters) - Chilean authorities said on Thursday they remained confident in a vaccine developed by China's Sinovac despite jitters elsewhere after researchers in Brazil
U.S. charges MIT professor with grant fraud for failing to disclose Chinese ties
By Nate Raymond BOSTON (Reuters) - A professor at the Massachusetts Institute of Technology who specializes in nanotechnology research was arrested on U.S. charges that he failed to disclose his ties
Qiagen warns against using standard tests to track coronavirus variants
By Ludwig Burger and Nikolaj Skydsgaard FRANKFURT/COPENHAGEN (Reuters) - Germany's Qiagen, a leading genetic testing supplier, on Thursday warned against re-engineering standard tests to monitor for
Michigan's former governor and health director charged in Flint water crisis
By Reuters Staff DETROIT (Reuters) - Michigan's former governor, former health director and seven others were charged on Thursday with crimes stemming from lead contamination of the city of Flint's
UPDATE 1-J&J COVID-19 vaccine on track for March rollout, still aims for 1 bln doses this year -exec
(Updates story published Jan. 13 with interim phase 1/2 trial results) By Julie Steenhuysen CHICAGO (Reuters) - Johnson & Johnson is on track to roll out its single-shot coronavirus vaccine in March,
WRAPUP-China steals march on West in developing nations' vaccine rollout
By Murad Sezer and Peter Graff ISTANBUL/LONDON (Reuters) - China is stealing a march on Western drugmakers in the COVID-19 vaccine race in developing nations, with Indonesia and Turkey rolling out
Italy police seize health ministry documents in probe into virus response
By Reuters Staff MILAN (Reuters) - Italian police seized documents from the health ministry in Rome on Thursday as part of an investigation into the handling of the initial phase of its coronavirus
REFILE-Fourth U.S. lawmaker tests positive for COVID-19 after U.S. Capitol attack
(Corrects typographical error in congressman's first name in first paragraph to make it "Adriano" instead of "Andriano") By Reuters Staff WASHINGTON (Reuters) - U.S. Representative Adriano Espaillat
Development mutations may be present in only one of monozygotic twins
By Marilynn Larkin NEW YORK (Reuters Health) - Although the genomes of monozygotic twins are often assumed to be identical, new research has found that mutations may be present at birth in one "
Hyperparathyroidism in the elderly appears undertreated
By David Douglas NEW YORK (Reuters Health) - Fewer than a third of elderly Medicare beneficiaries who may benefit from parathyroidectomy because of primary hyperparathyroidism (PHPT) actually receive
Neurodevelopmental deficits in children with single-ventricle physiology change with age
By Megan Brooks NEW YORK (Reuters Health) - Neurodevelopmental deficits in children with single-ventricle physiology change as children age, and early developmental scores are not a good predictor of
EU's top court gives opinion in first Irish language case, on pet medicine
By Kate Abnett BRUSSELS (Reuters) - The European Union's top court on Thursday issued an opinion in its first case heard in the Irish language, almost 50 years after Ireland joined the bloc, in a case
German public health official sees pandemic under control by year's end
By Reuters Staff BERLIN (Reuters) - Germany will have the coronavirus pandemic under control by the end of the year, but a new, fast-spreading strain of the virus risks exacerbating the situation, the
Two members of WHO delegation to Wuhan held back over health screening
By Thomas Peter and Stephanie Nebehay WUHAN, China/GENEVA (Reuters) - Two members of a World Health Organization-led team that arrived on Thursday in China's Wuhan city to investigate the origins of
Fourth U.S. lawmaker tests positive for COVID-19 after U.S. Capitol attack
By Reuters Staff WASHINGTON (Reuters) - U.S. Representative Andriano Espaillat on Thursday said he had tested positive for COVID-19, becoming the fourth member of Congress to announce they had
U.S. traffic deaths skyrocket after coronavirus lockdowns expire
By David Shepardson WASHINGTON (Reuters) - U.S. traffic deaths jumped dramatically after coronavirus lockdowns ended in 2020, rising 13.1% in the three months ending Sept. 30 to the highest rate since
EXPLAINER-What's behind varying efficacy data for Sinovac's COVID-19 vaccine?
By Reuters Staff (Reuters) - New efficacy data from Brazil on Sinovac's COVID-19 vaccine, for which there are now four widely different success rates, raised more questions than answers, as many
Microsoft, Cigna form coalition for digital records of COVID-19 vaccination
By Reuters Staff (Reuters) - Tech giants including Microsoft Corp, Oracle Corp and healthcare companies Cigna Corp and Mayo Clinic are part of a coalition pushing for digital records of people who get
Alexion pauses enrollment for COVID-19 study testing its rare blood-disorder drug
By Reuters Staff (Reuters) - Alexion Pharmaceuticals Inc on Wednesday paused enrollment in a late-stage study testing its rare blood-disorder drug in adults with severe COVID-19 requiring mechanical
COVID-19 infection gives some immunity, but virus can still be spread, study finds
By Kate Kelland LONDON (Reuters) - People who have had COVID-19 are highly likely to have immunity to it for at least five months, but there is evidence that those with antibodies may still be able to
Mucocutaneous eruptions appear to be common in hospitalized COVID patients
By Scott Baltic NEW YORK (Reuters Health) - Mucocutaneous eruptions (rashes) appear to be relatively common among adults hospitalized for COVID-19, and these eruptions may be connected to a more
Secondary Sjogren's syndrome, scleritis linked to corneal complications
By Reuters Staff NEW YORK (Reuters Health) - Patients with secondary Sjogren's syndrome (SS) are at increased risk of corneal complications compared to those with primary SS, and eyes with scleritis
Black patients disproportionately left off liver-transplant waitlists
By Megan Brooks NEW YORK (Reuters Health) - Liver-transplant waitlists at many U.S. centers under-represent Black patients compared with what would be expected based on their service area, new
Clinicians recommend hair pull test of up to two hairs for all textures
By Lisa Rapaport (Reuters Health) - A hair pull test with up to two hairs pulled, indicated in 2017 clinical practice guidelines, may be effective for evaluating hair loss disorders in individuals
Outdoor intraocular pressure screening clinic boosts patient management during pandemic
By Marilynn Larkin NEW YORK (Reuters Health) - A drive-through intraocular pressure (IOP) screening clinic minimized COVID-19 exposure for patients and clinicians by enabling eye pressure measurements
Immunotherapy plus chemo bests chemo alone in Asians with advanced NSCLC
By Marilynn Larkin NEW YORK (Reuters Health) - In Chinese patients with advanced non-squamous non-small-cell lung cancer (NSCLC), adding camrelizumab to carboplatin and pemetrexed was more effective
Just one drink a day can raise risk of developing atrial fibrillation
By Linda Carroll (Reuters Health) - Even light drinking, if it's regular, can raise a person's risk of developing atrial fibrillation, a new study suggests. An analysis of data from more than 100,000
Inhaled treprostinil improves walking distance in patients with pulmonary hypertension
By Gene Emery NEW YORK (Reuters Health) - Frequent daily inhalation treatment with the United Therapeutics drug treprostinil significantly increased the six-minute walking distance of people whose
Naltrexone-bupropion combo offers some hope for meth addiction
By Gene Emery NEW YORK (Reuters Health) - Treating moderate-to-severe methamphetamine abuse with injectable naltrexone and oral extended-release bupropion works better than placebo therapy, although
Many teens report driving challenges after concussion
By Lisa Rapaport (Reuters Health) - Teen drivers who sustain concussions may need to resume driving gradually by limiting trips, traveling shorter distances, and staying off the roads at night, a
J&J COVID-19 vaccine on track for March rollout, still aims for 1 bln doses this year -exec
By Julie Steenhuysen CHICAGO (Reuters) - Johnson & Johnson is on track to roll out its single-shot coronavirus vaccine in March, and plans to have clear data on how effective it is by the end of this
J&J COVID-19 vaccine could be available in Europe in April -source
By Francesco Guarascio BRUSSELS (Reuters) - Johnson & Johnson could deliver the first doses of its COVID-19 vaccine to Europe in April, an EU official told Reuters on Wednesday after a top lawmaker
As coronavirus stalks Brazil's Amazon, many die untreated at home
By Bruno Kelly and Gabriel Araujo MANAUS (Reuters) - Shirlene Morais Costa died at her home in the northern Brazilian city of Manaus on Monday, likely the latest victim of a devastating new wave of
Second year of pandemic 'could even be tougher' - WHO's Ryan
By Reuters Staff GENEVA (Reuters) - The second year of the COVID-19 pandemic may be tougher than the first given how the new coronavirus is spreading, especially in the northern hemisphere as more
REUTERS NEXT-WHO reform needed in wake of pandemic, public health experts say
By Kate Kelland and Josephine Mason LONDON (Reuters) - The role and remit of the World Health Organization (WHO) should be examined in the wake of the COVID-19 pandemic, and reforms will likely be
Critical care staff suffer trauma and severe anxiety due to COVID-19 - UK study
By Kate Kelland LONDON (Reuters) - Nearly half of staff working in intensive care units (ICU) in England in the COVID-19 pandemic have severe anxiety, depression or post-traumatic stress disorder,
China's Sinovac defends COVID-19 vaccine after disappointing Brazil data
By Reuters Staff KUALA LUMPUR/SINGAPORE (Reuters) - China's Sinovac Biotech defended the safety and efficacy of its experimental COVID-19 vaccine on Wednesday, after researchers in Brazil released
Ireland apologises for 'profound failure' at Mother and Baby homes
By Reuters Staff DUBLIN (Reuters) - Irish Prime Minister Micheál Martin formally apologised on Wednesday for the state's "profound failure" in its treatment of unmarried mothers and their babies in a
Printable chart suitable for stay-at-home visual evaluation
By David Douglas NEW YORK (Reuters Health) - A chart that can be downloaded or printed and mailed to patients appears effective in helping determine visual acuity via telephone assessments, according
Toxoplasma gondii infection may be tied to higher risk of brain cancer
By Megan Brooks NEW YORK (Reuters Health) - Data from two prospective studies point to an association between Toxoplasma gondii infection and the risk of glioma in adults, suggesting that reducing
Mitochondria a promising druggable target for Alzheimer's disease
By Megan Brooks NEW YORK (Reuters Health) - New research further supports the concept that targeting mitochondria is a promising therapeutic strategy for Alzheimer's disease (AD). In a paper in
Australian scientists raise doubts over vaccine efficacy as infections fall
By Swati Pandey SYDNEY (Reuters) - Australian scientists have raised questions over the efficacy of the AstraZeneca COVID-19 vaccine in establishing herd immunity, calling for a pause on its
Operation Warp Speed chief adviser resigns, Biden's transition official says
By Jeff Mason (Reuters) - Moncef Slaoui, the chief adviser for Operation Warp Speed, has resigned but will be available to the incoming Joe Biden administration as a consultant for about four weeks, a
J&J likely to apply for EU approval for COVID vaccine in February -lawmaker
By Reuters Staff BRUSSELS (Reuters) - U.S. firm Johnson & Johnson is likely to apply for EU approval for its COVID-19 vaccine candidate in February, a top lawmaker said on Wednesday. "EU Health
Labor induction at 41 weeks tied to lower morbidity, mortality than expectant management
By Lisa Rapaport (Reuters Health) - Inducing labor at 41 weeks may result in a lower risk of severe adverse perinatal and neonatal outcomes than expectant management until 42 weeks, a systematic
CDC to require negative COVID-19 tests for nearly all international air travelers -sources
By Reuters Staff WASHINGTON (Reuters) - The head of the U.S. Centers for Disease Control and Prevention (CDC) approved an order Tuesday expanding coronavirus testing requirements for nearly all
Left atrial appendage occlusion tied to less afib bleeding, mortality vs DOACs
By Marilynn Larkin NEW YORK (Reuters Health) - Patients with atrial fibrillation (AF) who undergo left atrial appendage occlusion (LAAO) have similar odds of stroke as patients managed with
Cooling vests may ease clinicians' PPE heat strain
By Linda Carroll (Reuters Health) - Nurses who wear cooling vests under their PPE feel less burdened by heat during their shifts, a new study finds. An analysis of data from seventeen nurses who wore
Immune factors linked to poor survival in Black breast cancer patients, immunotherapy potentially helpful
By Marilynn Larkin NEW YORK (Reuters Health) - Black women with breast cancer exhibit an "exhausted" T-cell profile associated with poor survival, and may benefit from checkpoint inhibitor therapy
